| |
| |
|
| Insider
Information: |
Fitzgerald Joseph Michael |
| Relationship: |
EVP & Group Pres, Card... |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
190,487 |
|
|
Indirect Shares
|
4,894 |
|
|
| Direct
Value |
$14,282,715 |
|
|
|
Indirect Value
|
$366,952 |
|
|
| Total
Shares |
195,381 |
|
|
| Total
Value |
$14,649,667 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP & Group Pres, Card... |
2024-05-13 |
190,487 |
2024-05-13 |
4,894 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
231 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 10
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
209,827 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,615 |
214,442 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,960 |
216,124 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,166 |
218,484 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
220,134 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
222,200 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,799 |
196,040 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,450) |
190,354 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
33,332 |
206,804 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
550 |
4,894 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
184,354 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,362 |
188,716 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,960 |
190,686 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
193,047 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
194,696 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,380 |
190,487 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, CRM |
• • – |
2012-07-29 |
4 |
D |
$5.22 |
$11,385 |
D/D |
(2,181) |
75,076 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, Endovascular |
• – – |
2010-07-29 |
4 |
D |
$5.60 |
$12,214 |
D/D |
(2,181) |
40,432 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, CRM |
• – – |
2012-02-12 |
4 |
D |
$5.93 |
$4,370 |
D/D |
(737) |
62,524 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, CRM |
• – – |
2012-02-16 |
4 |
D |
$5.97 |
$10,406 |
D/D |
(1,743) |
67,348 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, Endovascular |
• – – |
2010-06-21 |
4 |
D |
$6.18 |
$1,854 |
D/D |
(300) |
35,946 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, CRM |
• – – |
2012-02-24 |
4 |
OE |
$6.25 |
$2,713 |
D/D |
434 |
68,240 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Interven Cardio |
• • – |
2021-07-27 |
4 |
OE |
$6.28 |
$441,522 |
D/D |
70,306 |
309,086 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, CRM |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$7,263 |
D/D |
(1,142) |
70,590 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, Endovascular |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$12,651 |
D/D |
(1,815) |
46,776 |
0 |
- |
|
231 Records found
|
|
Page 5 of 10 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
